Naoko Takebe to IMP Dehydrogenase
This is a "connection" page, showing publications Naoko Takebe has written about IMP Dehydrogenase.
Connection Strength
0.490
-
IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol Cancer Ther. 2006 Feb; 5(2):457-66.
Score: 0.255
-
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients. Clin Cancer Res. 2004 Dec 15; 10(24):8301-8.
Score: 0.236